Berkshire Hathaway Inc. has demonstrated a clear selling bias in its recent insider transactions, with 21 sales and only 4 purchases recorded in its latest SEC Form 4 filings. The company has been actively divesting positions across multiple holdings, most notably in DaVita Inc. (DVA) and Liberty Latin America (LLYVA/K). On January 29, 2026, Berkshire sold $199.9 million worth of DVA shares, following earlier divestments totaling $54.3 million in October 2025 and $230 million in July 2025. The firm also executed a series of smaller but consistent sales in LLYVA/K throughout January 2026, with transactions ranging from $1.5 million to $5.5 million.
The only recent purchases were concentrated in Sirius XM Holdings (SIRI), with acquisitions totaling $63 million in July and August 2025. However, these buys were overshadowed by Berkshire’s $1.21 billion sale of Verisign (VRSN) shares on July 30, 2025, which remains the largest single transaction in the dataset. Overall, Berkshire’s total sell value of $2.07 billion since mid-2025 far exceeds its $1.77 billion in buys, reflecting a net reduction in equity exposure. The transactions suggest a strategic shift away from healthcare (DVA) and telecom (LLYVA/K), while maintaining selective interest in media (SIRI). The scale and consistency of these sales, particularly in DVA, indicate a deliberate unwinding rather than routine portfolio rebalancing.
AI-assisted summary